Ables Iannone Moore & Associates’s Eli Lilly LLY Stock Holding History

Ables Iannone Moore & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	1,343 -27	-2%	-$27.6K	0.86%	24
2026 Q1	$1.26M	Buy	1,370 +7	+0.5%	+$7.1K	0.75%	29
2025 Q4	$1.46M	Sell	1,363 -39	-3%	-$37.3K	0.8%	24
2025 Q3	$1.07M	Sell	1,402 -15	-1%	-$11.2K	0.62%	31
2025 Q2	$1.1M	Buy	1,417 +131	+10%	+$102K	0.69%	29
2025 Q1	$1.06M	Buy	1,286 +121	+10%	+$101K	0.72%	28
2024 Q4	$899K	Buy	+1,165	New	+$965K	0.56%	31
2024 Q1	–	Sell	-210	Closed	-$122K	–	186
2023 Q4	$122K	Buy	+210	New	+$123K	0.09%	63

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Ables Iannone Moore & Associates's LLY Position: Q2 2026 in Review

Ables Iannone Moore & Associates reduced its Eli Lilly (LLY) stake by 2% in Q2 2026, selling an estimated $27.6K and leaving 1,343 shares worth $1.61M. The position accounts for 0.86% of the portfolio, ranked #24.

Ables Iannone Moore & Associates first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. 917 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ables Iannone Moore & Associates held 1,343 shares of Eli Lilly worth $1.61M as of Q2 2026.
Ables Iannone Moore & Associates sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
Eli Lilly made up 0.86% of Ables Iannone Moore & Associates's portfolio in Q2 2026, its #24 holding.
Ables Iannone Moore & Associates first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
917 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.